Economic Outlook - The Federal Reserve has upgraded its U.S. economic growth outlook, expecting GDP to rise 1.6% in 2025, accelerating to 1.8% in 2026 and 1.9% in 2027 [2] - The Fed's dovish stance has led to increased optimism on Wall Street, with strategists from Wells Fargo, Barclays, and Deutsche Bank raising their S&P 500 targets due to resilient earnings, the AI investment cycle, and the prospect of lower rates [3] Market Performance - The S&P 500 has gained about 3.40% so far in September, rebounding around 33% since early April [1] - The S&P Global US PMI Composite Output Index was at 54.6 in August, indicating solid U.S. growth despite a slight decrease from July's 55.1 [5] - Financials and technology sectors were highlighted as top performers in August, contributing to the recent gains in the S&P 500 [5] Sector ETFs - The Technology Select Sector SPDR ETF (XLK) has gained 13.73% over the past three months and 19.87% over the past year, with major allocations to Microsoft (MSFT) and Apple (AAPL) [7] - The Financial Select Sector SPDR ETF (XLF) has gained 6.34% over the past three months and 19.81% over the past year, with significant exposure to JPMorgan Chase & Co. (JPM) [8] - The Industrial Select Sector SPDR ETF has gained 6.67% over the past three months and 17.23% over the past year, with RTX Corporation also included in its holdings [10] Health Care Sector - The Health Care Select Sector SPDR ETF (XLV) has an asset base of $33.76 billion and charges an annual fee of 0.08%, with top allocations to Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV) [11] - Despite a 10.55% decline over the past year, the Health Care Select Sector SPDR ETF has gained 2.54% quarter to date and 0.27% month to date [10][12]